Severe COVID-19 and Multisystem Inflammatory Syndrome in Children in Children and Adolescents

Allison M Blatz1, Adrienne G Randolph2

  • 1Department of Pediatrics, Division of Infectious Diseases, Children's Hospital of Philadelphia, 3401 Civic Center Boulevard, Philadelphia, PA 19104, USA.

Insights

Severe COVID-19 complications like acute respiratory failure and multisystem inflammatory syndrome in children (MIS-C) are rare in pediatric patients. These critical conditions often necessitate intensive care unit (ICU) support and specific treatments like immunomodulation for MIS-C.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Immunology

Background:

  • Severe complications from COVID-19 are infrequent in pediatric populations.
  • Key severe outcomes include acute respiratory failure and multisystem inflammatory syndrome in children (MIS-C).
  • MIS-C is a post-SARS-CoV-2 infection syndrome, typically emerging 3-6 weeks after mild or asymptomatic infection.

Purpose of the Study:

  • To summarize the nature of severe COVID-19 complications in children and adolescents.
  • To highlight the critical care needs and therapeutic strategies for these conditions.

Main Methods:

  • Literature review and synthesis of clinical observations regarding pediatric COVID-19 complications.
  • Analysis of treatment approaches for acute respiratory failure and MIS-C.

Main Results:

  • Acute respiratory failure and MIS-C are the primary life-threatening complications in pediatric COVID-19.
  • Both conditions frequently require intensive care unit (ICU) admission.
  • Immunomodulatory therapy is a key treatment for critical MIS-C to manage hyperinflammation and sequelae.

Conclusions:

  • While rare, severe COVID-19 complications in children demand prompt recognition and intensive care.
  • Management strategies focus on supportive care for respiratory failure and immunomodulation for MIS-C to mitigate severe outcomes.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
22
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
85
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
34
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.2K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
389
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
39